rs8094327 — NEDD4L

The Sodium Gatekeeper — How NEDD4L Variants Shape Your Blood Pressure Set Point

Your kidneys hold enormous power over your blood pressure. Each day they filter roughly 180 litres of plasma, and a critical circuit in the distal nephron decides how much sodium — and with it, water — gets reclaimed before the urine exits the body. The master regulator of that circuit is NEDD4L: an E3 ubiquitin ligase¹¹ E3 ubiquitin ligase
An enzyme that attaches ubiquitin tags to target proteins, marking them for removal from the cell surface that controls how many epithelial sodium channels (ENaC) remain active on the luminal membrane of kidney tubule cells at any given moment. When NEDD4L functions efficiently, it ubiquitinates ENaC subunits and pulls them off the membrane, limiting sodium reabsorption and keeping blood pressure in check. When NEDD4L function is reduced or its interaction with ENaC is weakened, the channels linger longer on the cell surface, sodium reabsorption climbs, and blood pressure follows.

rs8094327 is an intronic variant within NEDD4L on chromosome 18q21 that sits in strong linkage disequilibrium²² linkage disequilibrium
LD means two variants are co-inherited so frequently that tracking one effectively tracks both with rs4149601 (r² ≈ 0.95), the primary functional variant at this locus. rs4149601 is a G→A substitution at the last nucleotide of exon 1 that creates a cryptic splice site. The G allele preserves the standard transcript encoding a full-length protein with an intact C2 calcium-sensing domain; the A allele generates an alternatively spliced isoform that lacks the C2 domain, enabling stronger NEDD4L–ENaC binding and more efficient channel degradation. This locus illustrates a case where the "risk" and "protective" labels run counter to intuition: the G allele — which preserves normal NEDD4L structure — is paradoxically associated with higher salt sensitivity and greater reliance on ENaC-mediated sodium reabsorption, while the A allele generates an isoform that more aggressively downregulates ENaC activity.

The Mechanism

NEDD4L binds to ENaC (alpha, beta, and gamma subunits) through interactions between its WW domains³³ WW domains
Protein-protein interaction modules named for their conserved tryptophan residues and the PY motifs on the cytoplasmic tails of ENaC subunits. Once bound, NEDD4L polyubiquitinates the ENaC subunits, triggering their endocytosis and proteasomal or lysosomal degradation. The net effect is a reduction in the number of active ENaC channels in the apical membrane, which limits transepithelial sodium transport in the collecting duct.

The rs4149601 A allele creates an alternate splice acceptor site that causes preferential deletion of the C2 domain⁴⁴ preferential deletion of the C2 domain
The C2 domain is a calcium-dependent membrane-targeting module that tethers NEDD4L to the plasma membrane. Without the C2 domain, isoform I is constitutively cytoplasmic — but paradoxically this removes a spatial constraint on its WW-domain interactions, resulting in stronger and more efficient ENaC ubiquitination. Carriers of the A allele at rs4149601 (and the correlated A allele at rs8094327) therefore have greater ENaC downregulation capacity, lower basal ENaC surface expression, and lower sodium reabsorption. The G-allele carriers retain the full-length isoform with intact C2 domain but have the less efficient ENaC-downregulating isoform, leaving more ENaC channels active on the surface — raising the sodium reabsorption set point.

The Evidence

This locus has been robustly replicated across multiple independent cohorts. Dahlberg et al. (2007, PLoS ONE)⁵⁵ Dahlberg et al. (2007, PLoS ONE)
Dahlberg et al., Polymorphism in NEDD4L is associated with increased salt sensitivity, reduced levels of P-renin and increased levels of Nt-proANP. PLoS One, 2007 demonstrated in 39 normotensive Swedish adults that the GG genotype at rs4149601, when combined with the rs2288774 CC genotype, was associated with dramatically elevated salt sensitivity (median blood pressure increase of 18 mmHg on high salt vs 6 mmHg in non-carriers, p=0.007), significantly lower plasma renin (p=0.005), and higher circulating Nt-proANP — a marker of volume expansion and cardiac stretch. The physiological signature is classic low-renin, volume-dependent hypertension.

Svensson-Färbom et al. (2009)⁶⁶ Svensson-Färbom et al. (2009)
Svensson-Färbom et al., A functional variant of NEDD4L is associated with hypertension, antihypertensive response, and orthostatic hypotension. Hypertension, 2009 confirmed in a larger Swedish cohort that rs4149601 GG individuals had significantly higher diastolic blood pressure, lower plasma renin, and were at increased risk of hypertension. Uniquely, they were less susceptible to orthostatic hypotension — consistent with a higher plasma volume set point that buffers against the blood pressure drop on standing.

Treatment response data from two clinical trials clinched the pharmacogenomic relevance. Svensson-Färbom et al. (2011)⁷⁷ Svensson-Färbom et al. (2011)
Svensson-Färbom et al., A functional variant of the NEDD4L gene is associated with beneficial treatment response with β-blockers and diuretics in hypertensive patients. Journal of Hypertension, 2011 showed that G-allele carriers on β-blocker or diuretic monotherapy had markedly greater blood pressure reductions (SBP −19.5 vs −15.0 mmHg, p<0.001; DBP −15.4 vs −14.1 mmHg, p=0.02) and a relative risk of cardiovascular disease of 0.52 vs AA homozygotes (95% CI 0.36–0.74, p<0.001) over 4.5 years. Importantly, calcium channel blocker (diltiazem) efficacy was not genotype-dependent.

McDonough et al. (2013)⁸⁸ McDonough et al. (2013)
McDonough et al., Association of variants in NEDD4L with blood pressure response and adverse cardiovascular outcomes in hypertensive patients treated with thiazide diuretics. Journal of Hypertension, 2013 replicated in the PEAR trial (white hypertensive patients on hydrochlorothiazide): rs4149601 G-allele carriers showed significantly greater SBP and DBP reduction (SBP p=0.0303, DBP p=0.0372). The haplotype GC at rs4149601/rs292449 was the strongest predictor (p=0.0006 for SBP). Conversely, AG heterozygotes NOT treated with hydrochlorothiazide showed markedly elevated adverse cardiovascular event risk (OR 10.65, 95% CI 1.18–96.25, p=0.022), underlining that genotype–drug matching matters substantially for this locus.

Long-term cardiovascular data from Dahlberg et al. (2014)⁹⁹ Dahlberg et al. (2014)
Dahlberg et al., Genetic variation in NEDD4L, an epithelial sodium channel regulator, is associated with cardiovascular disease and cardiovascular death. Journal of Hypertension, 2014 followed 27,564 participants from the Malmö Diet and Cancer Study for 14 years. The salt-sensitivity genotype (rs4149601 GG + rs2288774 CC, present in 9.6% of participants) was associated with higher systolic and diastolic blood pressure, cardiovascular disease hazard ratio of 1.13 (95% CI 1.02–1.25), coronary event HR 1.20 (95% CI 1.06–1.37), and borderline cardiovascular mortality HR 1.17 (95% CI 0.99–1.37).

Practical Actions

For G-allele carriers at rs8094327, the underlying biology points toward low-renin, volume-dependent blood pressure elevation. The two most directly relevant practical implications are dietary sodium management and antihypertensive drug selection.

Sodium restriction is disproportionately effective in individuals with ENaC-driven volume expansion. Carriers of the high-salt-sensitivity genotype show nearly three times the blood pressure response to dietary sodium changes compared to non-carriers. Targeting sodium intake below 2,000 mg per day (rather than the standard <2,300 mg guidance) is particularly worth pursuing for GG individuals, who sit at the extreme of the salt-sensitivity spectrum.

Regarding antihypertensives, the evidence is directionally clear: if blood pressure treatment becomes necessary, G-allele carriers respond substantially better to thiazide diuretics and β-blockers than to calcium channel blockers. Coordinating with a physician who is aware of this pharmacogenomic data can improve treatment efficiency and potentially reduce cardiovascular event risk.

Blood pressure monitoring should be proactive — particularly in dietary contexts of higher sodium intake — and home monitoring allows GG individuals to observe their own salt sensitivity in real time.

Interactions

rs8094327 is in strong LD with rs4149601 (r² ≈ 0.95), the primary functional variant at this locus, and the two should be interpreted together. The combination of rs4149601 GG with rs2288774 CC at NEDD4L represents the salt-sensitivity compound haplotype with the strongest documented effects on plasma renin, Nt-proANP, and cardiovascular outcomes.

The NEDD4L pathway interacts with the renin-angiotensin-aldosterone system (RAAS): when ENaC is active and sodium is retained, plasma renin is appropriately suppressed. Individuals with the GG-associated high-ENaC phenotype already have low renin activity, which means ACE inhibitors and ARBs — drugs that work by interrupting RAAS — are mechanistically less well-matched than diuretics that directly reduce tubular sodium reabsorption. This gene-drug interaction has direct clinical relevance if hypertension develops.

NEDD4L is also involved in regulating the thiazide-sensitive cotransporter NCC in the distal tubule, and in broader ubiquitin-mediated regulation of TGF-β signaling. Variants affecting RAAS tone (e.g. ACE rs4646994, AGT rs699, AGTR1 rs5186) may compound with NEDD4L haplotype to set the overall blood pressure trajectory.